FDA
-
-
-
-
-
-
-
Bayer Granted Priority Review by U.S. FDA for Asundexian in Patients After a Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack
-
-
-
-
-
-
-
FDA clears Bayer's MEDRAD MRXperion system for 7T MRI compatibility
-
-
-
-
-
-
-
Actress and Menopause Advocate Gabrielle Union-Wade Partners with Bayer in the Lynkuet® (elinzanetant) ‘Life Doesn’t Stop for a Hot Flash’ Campaign for Moderate to Severe Hot Flashes Due to Men
-
-
-
-
-
-
-
U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
-
-
-
-
-
-
-
Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease
-
-
-
-
-
-
-
Processa Pharmaceuticals (PCSA) Appoints Khoso Baluch and James Neal to its Board of Directors and Justin Yorke to Chairman of the Board
-
-
-
-
-
-
322,214 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

